CU6.AX
Price:
$3.09
Market Cap:
$1.15B
Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, develops theranostic therapy and imaging products for the treatment of cancer in children and adults. Its lead product includes SARTATE, a targeted theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express somatostatin receptor 2. The company is also developing SAR-Bombesin, a pan cancer theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express gastrin releasing peptide receptor; and SAR-bisPSMA, a theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express prostate specific membrane antigen. The company has...[Read more]
Industry
Biotechnology
IPO Date
2021-08-25
Stock Exchange
ASX
Ticker
CU6.AX
According to Clarity Pharmaceuticals Ltd’s latest financial reports and current stock price. The company's current PE Ratio is -15.45. This represents a change of 51.78% compared to the average of -10.18 of the last 4 quarters.
The mean historical PE Ratio of Clarity Pharmaceuticals Ltd over the last ten years is -60.02. The current -15.45 PE Ratio has changed 2.47% with respect to the historical average. Over the past ten years (40 quarters), CU6.AX's PE Ratio was at its highest in in the June 2022 quarter at -3.27. The PE Ratio was at its lowest in in the December 2017 quarter at -112.09.
Average
-60.02
Median
-35.44
Minimum
-224.18
Maximum
-5.32
Discovering the peaks and valleys of Clarity Pharmaceuticals Ltd PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 349.11%
Maximum Annual PE Ratio = -5.32
Minimum Annual Increase = -85.90%
Minimum Annual PE Ratio = -224.18
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -12.41 | -62.59% |
| 2024 | -33.17 | 349.11% |
| 2023 | -7.39 | 38.90% |
| 2022 | -5.32 | -85.90% |
| 2021 | -37.70 | -31.97% |
| 2020 | -55.42 | -47.02% |
| 2019 | -104.60 | -53.34% |
The current PE Ratio of Clarity Pharmaceuticals Ltd (CU6.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-17.66
5-year avg
-19.20
10-year avg
-60.02
Clarity Pharmaceuticals Ltd’s PE Ratio is less than Neuren Pharmaceuticals Limited (17.28), greater than PYC Therapeutics Limited (-15.88), greater than Dimerix Limited (-25.21), greater than Mesoblast Limited (-29.06), less than Regis Healthcare Limited (46.52), greater than Orthocell Limited (-29.97), less than Immutep Limited (-7.95), less than Nanosonics Limited (62.27), greater than Island Pharmaceuticals Limited (-25.42), less than Clinuvel Pharmaceuticals Limited (18.11),
| Company | PE Ratio | Market cap |
|---|---|---|
| 17.28 | $2.48B | |
| -15.88 | $871.97M | |
| -25.21 | $354.23M | |
| -29.06 | $3.72B | |
| 46.52 | $2.28B | |
| -29.97 | $258.07M | |
| -7.95 | $493.09M | |
| 62.27 | $1.29B | |
| -25.42 | $122.53M | |
| 18.11 | $655.63M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Clarity Pharmaceuticals Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Clarity Pharmaceuticals Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Clarity Pharmaceuticals Ltd's PE Ratio?
How is the PE Ratio calculated for Clarity Pharmaceuticals Ltd (CU6.AX)?
What is the highest PE Ratio for Clarity Pharmaceuticals Ltd (CU6.AX)?
What is the 3-year average PE Ratio for Clarity Pharmaceuticals Ltd (CU6.AX)?
What is the 5-year average PE Ratio for Clarity Pharmaceuticals Ltd (CU6.AX)?
How does the current PE Ratio for Clarity Pharmaceuticals Ltd (CU6.AX) compare to its historical average?